Syneos Health Inc. (NASDAQ: SYNH) started the day on September 16, 2020, with a price decrease of -10.23% at $55.26. During the day, the stock rose to $58.35 and sunk to $54.545 before settling in for the price of $61.56 at the close. Taking a more long-term approach, SYNH posted a 52-week range of $30.02-$74.25.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 31.70%. Meanwhile, its Annual Earning per share during the time was 34.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 467.60%. This publicly-traded company’s shares outstanding now amounts to $104.20 million, simultaneously with a float of $61.30 million. The organization now has a market capitalization sitting at $5.80 billion. At the time of writing, stock’s 50-day Moving Average stood at $60.97, while the 200-day Moving Average is $57.42.
If we measure the efficiency of the company that is accounted for 24000 employees. It has generated 194,826 per worker during the last fiscal year. Meanwhile, its income per employee was 5,469. The stock had 3.65 Receivables turnover and 0.64 Total Asset turnover. For the Profitability, stocks gross margin was +16.84, operating margin was +7.30 and Pretax Margin of +2.18.
Syneos Health Inc. (SYNH) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. According to the most recent insider trade that took place on Aug 03, this organization’s Chief Executive Officer sold 10,289 shares at the rate of 65.07, making the entire transaction reach 669,464 in total value, affecting insider ownership by 246,687. Preceding that transaction, on Jul 15, Company’s Chief Executive Officer sold 37,868 for 60.14, making the whole transaction’s value amount to 2,277,495. This particular insider is now the holder of 261,154 in total.
Syneos Health Inc. (SYNH) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 6/29/2020, the organization reported $0.58 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at $0.48) by $0.1. This company achieved a net margin of +2.81 while generating a return on equity of 4.46. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.08 per share during the current fiscal year.
Syneos Health Inc.’s EPS increase for this current 12-month fiscal period is 467.60% and is forecasted to reach 3.89 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 9.41% through the next 5 years, which can be compared against the 34.80% growth it accomplished over the previous five years trading on the market.
Syneos Health Inc. (NASDAQ: SYNH) Trading Performance Indicators
Let’s observe the current performance indicators for Syneos Health Inc. (SYNH). It’s Quick Ratio in the last reported quarter now stands at 1.10. The Stock has managed to achieve an average true range (ATR) of 2.26. Alongside those numbers, its PE Ratio stands at $31.04, and its Beta score is 1.69. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.27. Similarly, its price to free cash flow for trailing twelve months is now 17.89.
In the same vein, SYNH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.78, a figure that is expected to reach 0.90 in the next quarter, and analysts are predicting that it will be 3.89 at the market close of one year from today.
Technical Analysis of Syneos Health Inc. (SYNH)
If we take a close look at the recent performances of Syneos Health Inc. (NASDAQ: SYNH), its last 5-days Average volume was 1.46 million that shows progress from its year to date volume of 0.69 million. During the previous 9 days, stock’s Stochastic %D was recorded 46.97% While, its Average True Range was 2.48.
Raw Stochastic average of Syneos Health Inc. (SYNH) in the period of the previous 100 days is set at 30.86%, which indicates a major rise in contrast to 7.94% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 54.28% that was higher than 39.50% volatility it exhibited in the past 100-days period.